Encorafenib and binimetinib followed by radiotherapy for patients with symptomatic BRAF mutated melanoma brain metastases: GEM1802/E-BRAIN clinical trial

被引：2

作者：

Marquez-Rodas, I. ^{[1
]}

Arance Fernandez, A. M. ^{[2
]}

Berciano Guerrero, M. A. ^{[3
]}

Garcia Castano, A. ^{[4
]}

Alamo De La Gala, M. D. C. ^{[5
]}

Gonzalez Cao, M. ^{[6
]}

Sanchez Maurino, P. ^{[7
]}

Diaz Beveridge, R. P. ^{[8
]}

Valduvieco, I. ^{[9
]}

Delgado, R. ^{[10
]}

Prada, P. J. ^{[11
]}

Puertas, E. ^{[12
]}

Romero, J. L. ^{[13
]}

Conde, A. ^{[14
]}

Alvarez, A. ^{[15
]}

Berrocal, A. ^{[16
]}

机构：

[1] Hosp Gen Univ Gregorio Maranon, Med Oncol Dept, Fdn Invest Biomed, Madrid, Spain

[2] Hosp Clin Barcelona, Med Oncol Dept, Barcelona, Spain

[3] Hosp Reg Univ Malaga Carlos Haya, Oncol Dept, Malaga, Spain

[4] HUMV Hosp Univ Marques Valdecilla, Med Oncol Dept, Santander, Spain

[5] Hosp Univ Virgen Macarena, Med Oncol Dept, Seville, Spain

[6] Hosp Univ Dexeus, Med Oncol, Barcelona, Spain

[7] Hosp Univ Reina Sofia, Med Oncol Dept, Cordoba, Spain

[8] Hosp Univ & Politecn La Fe, Med Oncol Dept, Valencia, Spain

[9] Hosp Clin Barcelona, Radiat Oncol Dept, Barcelona, Spain

[10] Hosp Univ Reg Malaga, Radiat Oncol Dept, Malaga, Spain

[11] HUMV Hosp Univ Marques Valdecilla, Radiat Oncol Dept, Santander, Spain

[12] Hosp Univ Dexeus, Radiat Oncol Dept, Barcelona, Spain

[13] Hosp Reina Sofia, Radiat Oncol Dept, Tudela, Spain

[14] Hosp Univ & Politecn La Fe, Radiat Oncol Dept, Valencia, Spain

[15] Hosp Gen Univ Gregorio Maranon, Radiat Oncol Dept, Madrid, Spain

[16] Hosp Gen Univ Valencia, Med Oncol Dept, Valencia, Spain

来源：

ANNALS OF ONCOLOGY | 2022年 / 33卷 / 07期

关键词：

D O I：

10.1016/j.annonc.2022.07.952

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

826P

引用

页码：S926 / S926

页数：1

共 50 条

[31] Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial
De Puysseleyr, Annemieke
Van De Velde, Joris
Speleers, Bruno
Vercauteren, Tom
Goedgebeur, Anneleen
Van Hoof, Tom
Boterberg, Tom
De Neve, Wilfried
De Wagter, Carlos
Ost, Piet
RADIATION ONCOLOGY, 2014, 9
[32] Pemetrexed and cisplatin combination with concurrent whole brain radiotherapy in patients with brain metastases of lung adenocarcinoma: a single-arm phase II clinical trial
Dinglin, Xiao-xiao
Huang, Yan
Liu, Hui
Zeng, Yin-duo
Hou, Xue
Chen, Li-kun
JOURNAL OF NEURO-ONCOLOGY, 2013, 112 (03) : 461 - 466
[33] Hair-sparing whole brain radiotherapy with volumetric arc therapy in patients treated for brain metastases: dosimetric and clinical results of a phase II trial
Annemieke De Puysseleyr
Joris Van De Velde
Bruno Speleers
Tom Vercauteren
Anneleen Goedgebeur
Tom Van Hoof
Tom Boterberg
Wilfried De Neve
Carlos De Wagter
Piet Ost
Radiation Oncology, 9
[34] Safety and clinical activity of ipilimumab in melanoma patients with brain metastases: retrospective analysis of data from a phase 2 trial
Weber, Jeffrey S.
Amin, Asim
Minor, David
Siegel, Jonathan
Berman, David
O'Day, Steven J.
MELANOMA RESEARCH, 2011, 21 (06) : 530 - 534
[35] Phase II trial of temozolomide and cisplatin followed by whole brain radiotherapy in non-small-cell lung cancer patients with brain metastases:: a GLOT-GFPC study
Cortot, A. B.
Geriniere, L.
Robinet, G.
Breton, J. -L.
Corre, R.
Falchero, L.
Berard, H.
Gimenez, C.
Chavaillon, J. -M.
Perol, M.
Bombaron, P.
Mercier, C.
Souquet, P. -J.
ANNALS OF ONCOLOGY, 2006, 17 (09) : 1412 - 1417
[36] Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial A TITE-CRM Phase I/II Clinical Trial
Kim, Michelle M.
Parmar, Hemant
Cao, Yue
Pramanik, Priyanka
Schipper, Matthew
Hayman, James
Junck, Larry
Mammoser, Aaron
Heth, Jason
Carter, Corey A.
Oronsky, Arnold
Knox, Susan J.
Caroen, Scott
Oronsky, Bryan
Scicinski, Jan
Lawrence, Theodore S.
Lao, Christopher D.
TRANSLATIONAL ONCOLOGY, 2016, 9 (02): : 108 - 113
[37] Treatment patterns and outcomes in BRAF V600E-mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
Gibney, Geoffrey T.
Gauthier, Genevieve
Ayas, Charles
Galebach, Philip
Wu, Eric Q.
Abhyankar, Sarang
Reyes, Carolina
Guerin, Annie
Yim, Yeun Mi
CANCER MEDICINE, 2015, 4 (08): : 1205 - 1213
[38] Treatment patterns and outcomes in BRAF V600E mutant melanoma patients with brain metastases receiving vemurafenib in the real-world setting
Gibney, Geoffrey Thomas
Marynchenko, Maryna
Galebach, Philip J.
Ayas, Charles
Liu, Nathan S.
Wu, Eric Qiong
Yim, Yeun Mi
Abhyankar, Sarang S.
Reyes, Carolina M.
Guerin, Annie
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[39] NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
Shin Kobayashi
Hideaki Bando
Akinobu Taketomi
Takeshi Takamoto
Eiji Shinozaki
Manabu Shiozawa
Hiroki Hara
Kentaro Yamazaki
Koji Komori
Nobuhisa Matsuhashi
Takeshi Kato
Yoshinori Kagawa
Mitsuru Yokota
Eiji Oki
Keigo Komine
Shinichiro Takahashi
Masashi Wakabayashi
Takayuki Yoshino
BMC Cancer, 23
[40] NEXUS trial: a multicenter phase II clinical study evaluating the efficacy and safety of the perioperative use of encorafenib, binimetinib, and cetuximab in patients with previously untreated surgically resectable BRAF V600E mutant colorectal oligometastases
Kobayashi, Shin
Bando, Hideaki
Taketomi, Akinobu
Takamoto, Takeshi
Shinozaki, Eiji
Shiozawa, Manabu
Hara, Hiroki
Yamazaki, Kentaro
Komori, Koji
Matsuhashi, Nobuhisa
Kato, Takeshi
Kagawa, Yoshinori
Yokota, Mitsuru
Oki, Eiji
Komine, Keigo
Takahashi, Shinichiro
Wakabayashi, Masashi
Yoshino, Takayuki
BMC CANCER, 2023, 23 (01)

← 1 2 3 4 5 →